{
  "retracted": false,
  "timestamp": 1480550400000,
  "updates": [
    {
      "timestamp": 1585336712394,
      "identifier": {
        "doi": "10.1038/srep38270"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/srep36371"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation"
}
